CFO SpotlightsCareers of chief financial officers, from the filings. Records as of October 28, 2026
  1. CFO Spotlights
  2. Profiles
  3. Danielle Watson

Profile

Danielle Watson

Chief Financial Officer, Treasurer, and Interim Secretary (Principal Financial and Accounting Officer), HeartSciences Inc.

In the seat. First published here October 28, 2026; built from records as of October 28, 2026.

Danielle Watson signed the annual report of HeartSciences Inc. as Chief Financial Officer, Treasurer, and Interim Secretary (Principal Financial and Accounting Officer); the report was filed on July 23, 2026, the most recent filing in the record that ties Danielle Watson to the seat.2

Seats

The seat in the record

CompanyTitle as filedStandingFilings
HeartSciences Inc. (HSCS)
Finance Services
Chief Financial Officer, Treasurer, and Interim Secretary (Principal Financial and Accounting Officer)In the seat2

Company names link to the company's page in the record at CFO Tribune, which holds the seat history.

The record

Filing by filing, latest first

  1. July 23, 202610-K filed

    Danielle Watson signed the annual report of HeartSciences Inc. on Form 10-K as Chief Financial Officer, Treasurer, and Interim Secretary (Principal Financial and Accounting Officer), filed July 23, 2026.

    /s/ Danielle Watson Chief Financial Officer, Treasurer, and Interim Secretary July 23, 2026 Danielle Watson (Principal Financial and Accounting Officer)

    [2] Annual report on Form 10-K by HeartSciences Inc., filed with the SEC on July 23, 2026. Read the filing. The record at CFO Tribune.

  2. Date not statedfiled June 26, 2026

    HeartSciences Inc. named Erik Ellingson to succeed Danielle Watson, with an effective date the filing does not state. Profile of Erik Ellingson.

    Watson, HeartSciences’ current Chief Financial Officer.

    [1] Filing by HeartSciences Inc., filed with the SEC on June 26, 2026. Read the filing. The record at CFO Tribune.

Sources

Sources

  1. Current report filed with the SEC, HeartSciences Inc.. U.S. Securities and Exchange Commission, EDGAR, filed June 26, 2026. sec.gov; record.
  2. Annual report on Form 10-K, HeartSciences Inc.. U.S. Securities and Exchange Commission, EDGAR, filed July 23, 2026. sec.gov; record.

Corrections and removal

If a line here is wrong, or Danielle Watson wants this profile taken down, write to corrections@cfospotlights.com. Corrections are made on the page with a dated note; removal requests are answered within 72 hours. The underlying filings stay public at the SEC.